Data-driven market development methodologies and systems help
clients realize full potential of their products and markets
CHICAGO--(BUSINESS WIRE)--Sep. 1, 2016--
Navigant (NYSE: NCI) today announced it acquired Dymedex Consulting,
LLC, a Minnesota-based firm that provides data-driven market analysis to
accelerate adoption and maximize growth for medical device companies.
Dymedex offers insights through global strategic market assessments,
tactical geography planning, and market landscape analysis.
The addition of the experienced Dymedex team, as well as the firm’s
proprietary market development tools and methodologies, expands
Navigant’s capabilities in the medical technology and life sciences
industries. Navigant also plans to make the Dymedex tools, methodologies
and expertise available to its healthcare clients.
“In today’s medical device market, it is critical that companies create
the conditions necessary to optimize growth, utilization, and adoption.
Dymedex has a proven methodology to assist companies in accelerating the
development of global markets,” said Eduardo Schur, managing director
and Global Life Sciences practice leader, Navigant. “And while Dymedex
has been successful in the medical technology field, we are excited by
the opportunity to expand their methodologies into other life sciences
areas such as pharmaceuticals and biotech.”
The Dymedex team, including founders Joseph Galatowitsch and Ross
Meisner, will join the Navigant Life Sciences practice within the
company’s Healthcare segment.
“Uncovering critical market insights and facilitating data-driven
decisions is vital to the success of life science and med tech
companies,” said Joseph Galatowitsch, co-founder of Dymedex Consulting
and managing director at Navigant. “The combination of Dymedex’s
proprietary tools and methodologies with Navigant’s deep industry
expertise and global footprint will enable our clients to fully
capitalize on their opportunities.”
Based in Minneapolis, Dymedex has evaluated over 100 different medical
technologies for their clients and worked in nearly 20 countries around
the world. With deep knowledge of the challenges clients face, Dymedex
helps clients address complex problems across multiple therapeutic and
clinical areas and works on a wide range of medical technologies and
business models, including monitoring and diagnostic products, therapies
of all types, surgical tools, disposables, capital equipment, and other
complex or combination devices.
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global
professional services firm that helps clients take control of their
future. Navigant’s professionals apply deep industry knowledge,
substantive technical expertise, and an enterprising approach to help
clients build, manage and/or protect their business interests. With a
focus on markets and clients facing transformational change and
significant regulatory or legal pressures, the Firm primarily serves
clients in the healthcare, energy and financial services industries.
Across a range of advisory, consulting, outsourcing, and
technology/analytics services, Navigant’s practitioners bring sharp
insight that pinpoints opportunities and delivers powerful results. More
information about Navigant can be found at navigant.com.
Dymedex is a market development consulting firm that helps medical
technology companies reach full market potential by using data-driven
market analysis and insight to improve decision-making. Dymedex has
developed over 100 customized medical technology market development
plans in all major markets globally. Dymedex understands the industry’s
challenges, and relies on more than 80 years of combined experience that
includes nearly every major disease and condition. Data-driven critical
thinking, shaped by broad experience, helps us consistently deliver key
insights. At Dymedex, we are driven to provide foundational scientific
market analysis that organizations can rely on to move forward with
View source version on businesswire.com: http://www.businesswire.com/news/home/20160901005264/en/
Source: Navigant Consulting, Inc.
Navigant Investor Relations